Amarin Corp. (AMRN) Tops Q2 EPS by 5c

Go back to Amarin Corp. (AMRN) Tops Q2 EPS by 5c

Amarin Reports Second Quarter 2023 Financial Results

August 2, 2023 7:11 AM EDT

-- Company Reported Total Net Revenues of $80 Million in Second Quarter 2023; Total Net Revenues Included Net Product Revenues of $65 Million, $15 Million in License and Royalty Revenues, of Which $11 Million is Non-Cash --

-- Delivered Positive Cash Flow of $9 Million in the Quarter with a Cash Position of $313 Million --

-- Comprehensive Cost Reduction Plan Implemented in July with Expected Savings of $40 Million Over 12 Months--

-- Received Positive Recommendation from Spanish Drug Pricing Committee for National Reimbursement of VAZKEPA® (icosapent ethyl) in Spain --

... More